New CADTH Processes
Expanding CADTH’s Drug Review Processes to Include Radiopharmaceuticals
In collaboration with the participating jurisdictions, CADTH is pleased to ... Read More
News
17
Mar2017
16
Mar2017
The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of February 28, 2017:
... Read More
15
Mar2017
CADTH Special Event: New Guidelines for the Economic Evaluation of Health Technologies: Canada
/ CADTH, What's New
CADTH is hosting an online or in person event on Tuesday, March 28, 2017 to release the fourth edition of ... Read More
15
Mar2017
INESSS Upcoming Meetings with Manufacturers – October 2017 “Liste des médicaments”
INESSS is offering an opportunity for in-person meetings to manufacturers ... Read More
17
Feb2017
This is a reminder to all patentees of their filing requirements to the PMPRB respecting revenues and research and development ... Read More
06
Feb2017
Kaitlyn Proulx appointed Managing Director / Directrice Générale
Neil Palmer, Founder and Principal Consultant of PDCI Market Access Inc is pleased ... Read More
06
Dec2016
Health Canada Releases Guidance Document for Biosimilar Biologic Drug Submissions
/ Canada, What's New
On December 2, 2016, Health Canada released its updated guidelines for biosimilar biologic drug submissions. The document will provide guidance ... Read More
02
Dec2016
As a first step to framework modernization, the Patented Medicines Prices Review Board (PMPRB) is undertaking major consultations regarding possible ... Read More